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ABSTRACT 
Background: Obsessive-compulsive disorder (OCD) is a severe and heterogenous mental 
disorder characterized by intrusive thoughts, urges or images, followed by repetitive behaviors 
aimed to reduce the associated anxiety. Tic disorders are neurodevelopmental movement 
disorders consisting of recurring, involuntary, rapid, and sudden non-rhythmic motor 
movements or vocalizations. While OCD affects approximately 2% of the population and tic 
disorders affect about 1% of the population, a much smaller proportion of individuals seek help 
and come into contact with health services. Both disorders are associated with considerable 
distress and impairment. Little is known about the etiology and long-term health consequences 
of OCD and tic disorders. Tic-related OCD may constitute a biologically meaningful subtype 
of OCD but current evidence supporting this is incomplete.  
Aims: The overarching aims of the studies in this thesis are: 
• to synthesize the literature on potential environmental risk factors for OCD, 
• to identify perinatal risk factors that may be in the causal pathway to OCD and tic 
disorders, 
• to examine the validity of tic-related OCD as a potentially meaningful subtype of OCD, 
and 
• to examine the risk of metabolic and cardiovascular disorders in individuals with OCD 
and tic disorders. 
Methods: In study I we conducted a systematic review of potential environmental risk factors 
for OCD following the PRISMA guidelines. 
In studies II and III, we used population-based birth cohorts to estimate the risk of OCD and 
tic disorders in individuals with a range of perinatal events, including maternal smoking during 
pregnancy, labor presentation, obstetric delivery, gestational age, birth weight, Apgar score, 
and head circumference, compared to the unaffected general population. 
In study IV, we used a birth cohort to estimate the risk of OCD in relatives of individuals with 
OCD with and without comorbid tics, compared to relatives of unaffected individuals. 
In studies V and VI, we used total population cohorts to estimate the risk of metabolic and 
cardiovascular disorders in individuals with OCD or tic disorders, compared to the unaffected 
general population. 
Studies II, III, V, and VI applied sibling comparison designs to further control for shared 
familial confounding, and the role of other co-occurring psychiatric conditions was 
systematically evaluated. All studies adjusted for measured confounders. 
Results: Including 128 studies of environmental risk factors for OCD, study I found that the 
methodological limitations of these studies precluded drawing strong conclusions. However, 
the systematic review identified several promising areas of potential risk factors, which could 
be considered as reasonable starting points for further research. 
Studies II and III found that several adverse perinatal events were associated with an increased 
risk of OCD and tic disorders, independent from measured confounders and unmeasured 
familial confounding. These perinatal events included breech presentation, cesarean section, 
preterm birth, low birth weight. Maternal smoking during pregnancy emerged as a potentially 
specific risk factor for OCD. A cumulative pattern was also found, whereby the greater the 
number of adverse perinatal events, the greater the risk for OCD and tic disorders. 
Study IV found that relatives of individuals with tic-related OCD are at higher risk of having 
OCD themselves than relatives of individuals with non-tic-related OCD, independent of age at 
first OCD diagnosis. The same pattern was not observed, when we created additional 
subgroups based on other neuropsychiatric comorbidities, like ADHD or autism spectrum 
disorders (ASD). The results confirm the hypothesis that individuals with history of tics 
constitute a particularly familial subtype of OCD. 
Studies V and VI found that both OCD and tic disorders are associated with increased risks of 
metabolic and cardiovascular disorders in general, and with obesity, type 2 diabetes mellitus, 
and circulatory system diseases in particular. The risks were considerably higher in individuals 
with tic disorders than in those with OCD, but were significantly reduced in the sibling 
comparisons. 
Conclusions: Study I proposed a roadmap for future research of environmental risk factors for 
psychiatric disorders to improve upon the methodological limitations of previous studies. The 
road map emphasized using prospective longitudinal data at the population level, using 
standardized measures, and applying genetically informative study designs. 
Following the plan suggested in study I, studies II and III found a range of perinatal risk factors 
for OCD and tic disorders, independent of familial confounding. Dose-response associations 
were also observed for the number of adverse perinatal events, in that the greater the number 
of events, the greater the risk for either disorder. This cumulative effect provides some hope 
that, in the future, it may be possible to derive environmental risk scores for these disorders. 
Study IV found that tic-related OCD is a particularly familial subtype of OCD, supporting the 
validity of the DSM-5 tic-related OCD specifier. Identifying homogeneous subgroups of OCD 
may inform treatment selection, earlier detection, and future studies of OCD etiology, including 
ongoing gene-searching efforts. 
Studies V and VI found that OCD and tic disorders are associated with increased risks for 
metabolic and cardiovascular disorders, independent of shared familial confounding. The 
results emphasize the importance of monitoring the long-term physical health of individuals 
with OCD and tic disorders. These results further suggest that lifestyle interventions may be 
required alongside other standard evidence based treatments to reduce the risk of premature 
mortality in these patients.  
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1 INTRODUCTION 
Obsessive-compulsive disorder (OCD) and tic disorders, including Tourette syndrome and 
chronic motor or vocal tic disorders, are complex neuropsychiatric disorders of unclear etiology 
that often co-occur in the same individuals. We know that both disorders are familial and likely 
genetic, but the specific genes involved are yet to be identified. Large-scale gene searching 
efforts are currently underway, and identification of meaningful biological subtypes may help 
accelerate this process. It also seems clear that a substantial proportion of the liability to OCD 
and, to lesser extent tic disorders, is not of genetic origin. Little is known about the potential 
environmental risk factors that presumably interact with genetic risk factors to cause these 
disorders. Similarly, little is known about the long-term adverse health consequences 
associated with OCD and tic disorders. This is largely because it is often unfeasible to follow 
patients for several decades; the study of such distal health outcomes requires a long-term 
perspective.  
The vast Scandinavian nationwide registers, which contain administrative records from entire 
populations ‘from cradle to grave’, and a wealth of high-quality healthcare data prospectively 
collected over several decades, provide unique opportunities to study environmental risk 
factors as well as the long-term consequences of these disorders.  
The broad aims of this thesis were to investigate potential perinatal risk factors for OCD and 
tic disorders, to investigate whether tic-related OCD is a particularly familial subtype of OCD, 
and to investigate some of the potential long-term health complications following the onset of 
these disorders. 
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2 BACKGROUND 
OCD is a mental disorder characterized by recurrent, persistent, and intrusive thoughts, urges, 
or images causing marked anxiety or distress. These, in turn, prompt repetitive behaviors or 
mental acts aimed at preventing or reducing the anxiety or the distress. The obsessions and 
compulsions are time-consuming and/or cause clinically significant distress or impairment. 
Tics are sudden, rapid, recurrent, non-rhythmic motor movements or vocalizations. Tic 
disorders are neurodevelopmental movement disorders including Tourette syndrome, 
characterized by multiple motor and vocal tics, and chronic (or persistent) tic disorder, 
characterized by multiple motor or vocal tics. For simplicity, henceforth both kinds of disorders 
will be referred to as “tic disorders”. The frequency of the tics can wax and wane, but they need 
to have persisted for more than one year for a tic disorder diagnosis.1 OCD and tic disorders 
have a severe negative impact on functioning in everyday life. Individuals with OCD or tic 
disorders experience lower quality of life than individuals without the disorders.2,3 More 
specifically, both OCD and tic disorders have been associated with educational attainment 
difficulties, including being less likely to finish upper secondary school, finish a university 
degree, and finish a post-graduate degree, compared to those without the disorders.4,5. Further, 
OCD has been associated with increased risks of labor market marginalization, including 
higher rates of long-term unemployment, long-term sick-leave, and disability pension.6 
Both OCD and tic disorders are relatively common psychiatric disorders. OCD has a reported 
lifetime prevalence of approximately 2%,7 whereas the prevalence of tic disorders is about 
1%.8,9 However, these figures are based on epidemiological surveys and do not reflect the 
actual prevalence of help-seeking individuals, which is thought to be much lower.10 Whereas 
the prevalence of OCD is similar in both males and females,1  tic disorders are more common 
in males.11 OCD is widely acknowledged to have two peaks of age at onset, one during 
childhood (mean age of 11-13), and another in early adulthood (mean age 23-25).e.g.,12,13 By 
contrast,  tic disorders are by definition childhood-onset disorders and the first symptoms 
typically first manifest in early childhood (typically between ages 4 and 6).1,14 A great majority 
of OCD and tic disorders patients have other co-occurring psychiatric disorders. In OCD, the 
most common are other anxiety disorders (75.8%) and mood disorders (63.3%),7 and as many 
as 29% of OCD patients have lifetime comorbid tic disorders.15 In Tourette syndrome, the most 
common co-occurring disorders are OCD (66.1%) and attention-deficit/hyperactivity disorder 
(ADHD; 54.3%), followed by anxiety disorders (36.1%) and mood disorders (29.8%).16 
Both OCD and tic disorders are familial disorders, meaning that relatives of individuals with 
either disorder are more likely to have that same disorder.17,18 However, they are also familial 
cross-disorder, in that relatives of individuals with one of the disorders are more likely to have 
the other disorder,19-23 suggesting some shared genetic etiology. Patients with OCD who also 
have a history of tic disorders have been observed to present with distinct clinical 
characteristics, compared to those without tic disorders. The co-occurrence of OCD and tic 
disorders in the same individual may represent a subtype of OCD, which led to the inclusion 
of a tic-related OCD specifier in the fifth edition of the Diagnostic and Statistical Manual of 
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Mental Disorders (DSM-5).1,24 These differential features include tic-related OCD being linked 
to early age of onset,21,25,26 a greater proportion of males,15,20,26-28 and the course of the disorder 
being characterized by an early peak in the severity of the obsessive-compulsive symptoms, 
followed by an increased likelihood of remission,29,30 compared to non-tic-related OCD. The 
symptoms in tic-related OCD have also been reported to include higher rates of symmetry and 
sexual/aggressive obsessions26,28,31 and sensory phenomena preceding the compulsions.15,32 
While less supported, tic-related OCD has also been associated with a higher number of 
comorbidities33 and higher rates of ADHD and autism than non-tic-related OCD.31 Tic-related 
OCD could potentially guide choice of treatment, as some studies have reported that these 
patients may not respond to selective serotonin reuptake inhibitors (SSRIs).34,35 However, other 
studies have not confirmed this.36,37 
 
2.1 ETIOLOGY 
The causes of OCD and tic disorders remain largely unknown. Controlled family studies have 
consistently found both disorders to be familial,22,23,38-40 with first degree relatives of 
individuals with OCD being approximately 4–5 times more likely to have OCD 
themselves18,40,41 and of individuals with tic disorders being 18-19 times as likely to have 
chronic tics themselves,17,40 compared to relatives of unaffected controls. This risk decreases 
as the genetic distance to the relative increases,17,18 strongly suggesting a genetic basis for the 
observed familiality. The genetic basis has been additionally supported by large population-
based twin studies in nonclinical populations, particularly for OCD, finding that additive 
genetic effects contribute 38-40% and non-shared environmental effects contribute 50-52% to 
the variance of OCD.42 In twin studies, the heritability estimates for tic disorders have been 
less consistent, with effects varying between 28% and 56%,39,43-47 whereas in family studies 
the heritability has been estimated to be as high as 77%.17 The broad range of estimates may 
be explained by the variations in methods of assessment, age groups, data collection, and 
definitions of tic disorders. 
Thus, it seems clear that both OCD and tic disorders have some genetic basis. However, 
modestly sized genome-wide association studies (GWAS) have not been able to identify any 
single-nucleotide polymorphism (SNPs) firmly associated with OCD,48 and only some 
promising but no definite SNPs for tic disorders.49 Based on the encouraging results emerging 
from the genetics of schizophrenia and other mental disorders,50-52 it is widely expected that a 
worldwide increase in sample sizes will return the first replicable set of risk genes for both 
disorders. Several worldwide efforts are currently ongoing to achieve such aim, and 
Scandinavian countries have a major role to play in such efforts.53 
 
  5 
2.1.1 Environmental risk factors 
Based on the current knowledge, it seems likely that neither disorder is fully explained by 
genetic factors. In OCD, at least half of the liability may not be of genetic origin, whereas in 
tic disorders, a smaller role of environmental risk may be expected, given the higher heritability 
of the disorder. Environmental risk factors for OCD and tic disorders, that may interact with 
genetic factors, are therefore as important to identify as genes, since some environmental 
factors may be more amenable for intervention or prevention strategies. Additionally, the 
identification of specific environmental risk factors for OCD and tic disorders may also 
facilitate future genetic research, as genes may not be sufficient to cause psychopathology but 
may be dependent on other necessary causes in the form of environmental factors.54 On the 
other hand, genetic susceptibility may be a requirement for environmental factors to increase 
risks, but this conjecture requires empirical research. 
A quick scan of the literature revealed that a number of potential environmental risk factors 
may be associated with increased risk for OCD and tic disorders. However, given the vast and 
methodologically heterogeneous nature of the literature, it was difficult to draw firm 
conclusions. At the time this thesis began, there were no systematic reviews of environmental 
risk factors for OCD, whereas there were a few reviews of risk factors for tic disorders.55,56 
Thus, a systematic review of the OCD literature seemed warranted prior to initiating empirical 
studies on the subject.  
 
2.2 IS TIC-RELATED OCD A MEANINGFUL SUBTYPE OF OCD? 
One potential obstacle for the identification of risk genes for OCD and tic disorders is the 
heterogeneity of these disorders.57-61 There have been several approaches to dissecting OCD 
and tic disorders into more homogeneous subtypes. 
Symptom dimensions have been studied mainly in OCD, but also in tic disorders. A meta-
analysis of factor analyses of OCD symptoms found four dimensions consisting of symmetry, 
forbidden thoughts, cleaning, and hoarding symptoms.62 Cluster analyses of tic disorders 
symptoms have also found dimensions, mostly consisting of combinations of the degree of 
complexity of the tics, whether they are vocal and, to some extent, which part of the body the 
tic involves.63,64 The dimensions in both OCD and tic disorders have in turn been associated 
with other clinical characteristics, such as patterns of psychiatric comorbidity, familial patterns, 
neural correlates and treatment response,63,65,66 albeit not consistently. 
Subtyping based on comorbid psychiatric disorders have also been examined in both OCD and 
Tourette syndrome. For example, three classes of OCD have been identified, consisting of 
simple OCD, OCD with comorbid tics, and OCD with affective syndromes and panic 
disorder.67 The main three classes of Tourette syndrome all included OCD or obsessive-
compulsive symptoms.61 Additionally, autism-related OCD68 and early onset OCD19,20 have 
 6 
also been proposed subtypes of OCD. Of all these efforts, the most promising subtype of OCD 
is arguably the tic-related OCD subtype.25 
Supporting the tic-related OCD subtype are three twin studies, finding modest genetic 
correlations between obsessive-compulsive symptoms and tics.43,46,69 Recently, GWAS data 
was analyzed to estimate shared heritability between psychiatric disorders, finding a 0.43 
genetic correlation between OCD and Tourette syndrome.70 In a genome-wide analysis 
examining polygenic risk scores in OCD and Tourette syndrome, no significant polygenic 
signal was observed between the two disorders. However, it was observed that the polygenic 
risk scores of OCD increased when excluding individuals with both OCD and Tourette 
syndrome, despite the decrease in sample size.71 In a previous study by the same team, the 
genetic correlation between the disorders increased when tic-related OCD cases were 
excluded.72 These results may suggest that tic-related OCD possesses a different underlying 
genetic architecture than non-tic-related OCD. The genetic effects might even be stronger in 
tic-related OCD, compared to non-tic-related OCD, as has been further suggested by a few 
family studies indicating that tic-related OCD might be more familial than non-tic-related 
OCD.20,22,40 However, these studies were generally limited by small samples from specialist 
clinics. Furthermore, tic-related OCD was not the main focus of these studies and did therefore 
not take potential confounding factors specific to tic-related OCD cases into account. 
While there has been a considerable amount of work on the clinical features of tic-related OCD, 
there has yet to be a study investigating the validity of it being a meaningful subtype of OCD. 
If tic-related OCD would prove to be more familial than non-tic-related OCD, this would add 
to the evidence for tic-related OCD being a distinct subtype of OCD and, potentially, would 
inform future gene-searching efforts. 
 
2.3 LONG-TERM HEALTH CONSEQUENCES 
Both OCD and tic disorders have been associated with about double the risk of premature 
death, compared to individuals without the disorders.73,74 Patients with OCD have also been 
reported to be almost 10 times more likely and patients with tic disorders more than four times 
more likely to die by suicide than the general population.75,76 The mechanisms behind the 
increased risk of premature death from natural causes, however, have received little attention. 
One of the most plausible candidates contributing to mortality in tic disorders is metabolic 
syndrome, a collection of risk factors for metabolic and cardiovascular disorders, which has 
been associated with other psychiatric disorders77,78 and in turn with increased mortality.79-81 
In a naturalistic Italian study of 104 OCD patients from a specialist clinic, metabolic syndrome 
was present in 21.2% and was further associated with long-term antipsychotic medication.82 
However, the small sample, clinical setting, cross-sectional design, and absence of a control 
group precludes any firm conclusions. In tic disorders, metabolic and cardiovascular symptoms 
have only been examined as potential side effects in the context of trials of psychiatric 
medication.83-86 In previous studies, long-term use of psychiatric medication has been 
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associated with increased risk of metabolic syndrome.87 Evidence-based pharmacological 
treatment for OCD includes high doses of serotonin reuptake inhibitors (SRIs),88 while tic 
disorders are commonly treated with antipsychotic medication.89,90 If individuals with OCD 
and tic disorders were to have an increased risk of metabolic syndrome, and other related 
adverse health consequences, there should be an additional emphasis on monitoring the general 
health of these patients and to implement interventions aimed at reducing health risks, 
something that has been neglected in these patient groups.  
 
2.4 CONCLUSIONS AND RATIONALE 
There are big gaps to be filled in understanding psychiatric disorders in general, and of OCD 
and tic disorders in particular. Whereas gene-searching efforts are well underway for both 
disorders, less emphasis has been put on identifying environmental risk factors for OCD and 
tic disorders. The identification of more homogeneous subgroups of individuals (e.g., tic-
related OCD) might also facilitate more effective ways of finding risk factors for these 
disorders. While OCD and tic disorders are associated with considerable impairment, little is 
still known about the long-term effects on the physical health of the patients. Knowing specific 
long-term health consequences for people with OCD or tic disorders could inform intervention 
strategies beyond the treatment of the psychiatric symptoms. This thesis capitalizes on the 
wealth of information contained within the Swedish nationwide registers and aims to contribute 
to the understanding of the etiology and health consequences of OCD and tic disorders. 
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3 AIMS 
The overarching aim of this PhD project was to fill in some of the gaps of knowledge about 
OCD and tic disorders, by investigating environmental risk factors and adverse health 
consequences of the disorders, and the validity of tic-related OCD as a particularly familial 
subtype of OCD. 
The main aims of the individual studies in the thesis were: 
Study I To systematically synthesize the literature on potential environmental risk 
factors for OCD. 
Studies II & III To identify perinatal risk factors that may be in the causal pathway to 
OCD and tic disorders. 
Study IV To examine the validity of tic-related OCD as a potentially meaningful 
subtype of OCD. 
Studies V & VI To examine the risk of metabolic and cardiovascular disorders in 
individuals with OCD and tic disorders. 
 
 
Figure 1. Overview of the topics examined in studies II-VI 
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4 METHODS 
4.1 ETHICAL APPROVAL 
No ethical approval was required for study I (systematic review). Studies II-VI were approved 
by the Regional Ethical Review Board in Stockholm (reference number 2013/862-31/5). These 
studies were register-based and no individuals were identifiable at any time, therefore the 
requirement for informed consent was waived. 
 
4.2 STUDY DESIGNS 
This thesis contains one systematic review and five observational studies. The observational 
studies are register-based with prospectively collected data from several Swedish National 
Registers. As such, the cohort design is generally the best suited for the data, including as many 
individuals as possible and taking advantage of the long-term follow up for different outcome 
variables. 
Potential measured confounders that could be associated with both exposure and outcome were 
adjusted for. However, there may still be other, unmeasured factors that better explain the 
associations. A useful method to control for some unmeasured confounders is to compare full 
siblings within the same family with each other. By doing so, several familial factors, such as 
shared environmental factors (e.g., socioeconomic status, parental education), and about 50% 
of the genetic liability, are held constant in the analyses. If, for example, socioeconomic status 
is associated with both the exposure (e.g., having OCD) and the outcome (e.g., metabolic and 
cardiovascular disorders), comparing siblings from the same family would effectively control 
for this confounder. For this reason, studies II, III, V, and VI all employed full sibling 
comparisons to control for unmeasured confounders shared between siblings. 
 
4.2.1 Systematic review in study I 
Study I is a systematic review of environmental risk factors for OCD, following the PRISMA 
(Preferred Reporting Items for Systematic reviews and Meta-Analyses) guidelines. The 
PRISMA statement consists of a 27 item checklist and a four-phase flow chart intended to help 
authors improve the reporting of systematic reviews and meta-analyses.91 The items in the 
checklist cover all sections of the review (i.e., title, abstract, introduction, methods, results, 
discussion, and funding) and include recommendations aimed at promoting transparency and 
complete reporting of the included studies. 
Studies included in the systematic review were chosen in the basis of a series of inclusion and 
exclusion criteria. Papers were included if they reported data on OCD as the primary outcome, 
used standardized diagnostic criteria to define OCD diagnosis, reported on potential 
environmental risk factors, and included a control group, a comparison to general population 
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data, or a well-characterized clinical cohort without control group. On the other hand, studies 
that did not include OCD-specific data, did not provide information on the assessment 
procedure, and those on obsessive-compulsive personality disorder and case reports or small 
case series were excluded.  
 
4.2.2 Birth cohorts in studies II & III – perinatal risk factors 
By means of a birth cohort design, studies II and III examined the association between adverse 
perinatal events and having OCD and tic disorders, respectively. For study II, we identified 
from the Medical Birth Register all individuals born in Sweden between January 1, 1973 and 
December 31, 1996, and for study III, those born between January 1, 1973, and December 31, 
2007. The reason behind the difference in time periods was motivated by the differences in the 
course of the disorders and wanting to give the individuals included in the respective cohorts 
enough time to develop the disorders. Everyone included in the cohort was followed from birth 
until the first date of a recorded diagnosis of OCD (study II) or tic disorder (study III), death, 
emigration, or end of follow-up, whichever came first. 
 
4.2.3 Birth cohort and sub-cohorts of relatives in study VI – family clustering 
of tic-related OCD 
Study IV examined the risk of OCD in relatives of individuals with tic-related OCD and in 
relatives of individuals with non-tic-related OCD, compared to relatives of unaffected 
individuals. Tic-related OCD was defined as having a lifetime diagnosis of OCD and a lifetime 
diagnosis of any tic disorder registered in the National Patient Register (NPR). We identified 
all individuals born in Sweden between January 1, 1967 and December 31, 2007 from the Total 
Population Register. Thus, the oldest individuals included were 6 years old in 1973, when the 
coverage of psychiatric disorders in the NPR was good, and the youngest were 6 years old at 
end of follow-up on December 31, 2013. This age was selected as inspection of the data in the 
NPR indicated that an OCD diagnosis before age 6 was very rare. From this birth cohort, we 
used information on parentage from the Multi-Generation Register to create sub-cohorts 
consisting of all twins (combining both monozygotic and dizygotic), full siblings, maternal and 
paternal half siblings, and cousins. In each sub-cohort, we then followed everyone from birth 
until the first date of a recorded OCD diagnosis, emigration, death, or the end of follow-up 
(December 31, 2013), whichever came first. Individuals who died or emigrated before 6 years 
of age and individuals with conflicting migration dates were excluded from the study 
population. 
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4.2.4 Total population cohorts in studies V and VI – metabolic and 
cardiovascular disorders 
Study V examined the association between having OCD and developing metabolic and 
cardiovascular disorders. Study VI examined the association between having tic disorders and 
metabolic and cardiovascular disorders. As metabolic and cardiovascular disorders are 
generally developed later in life, the birth cohort design would not have provided enough 
follow-up time to capture all outcomes. For this reason, a total population cohort design was 
applied instead, including everyone living in Sweden anytime between 1973 and 2013. 
For study V, people who emigrated or died before age 6 were excluded; as described in study 
IV above, this was based on recorded diagnoses of OCD before age 6 being very rare. 
Additionally, in study V, individuals with organic brain disorder, psychotic disorder, bipolar 
disorder, pervasive developmental disorder, Tourette syndrome, and chronic tic disorders were 
also excluded from the cohort since these disorders are commonly medicated with 
antipsychotics, which in turn have been associated with metabolic complications.87 Study VI 
used a less restrictive cohort, without restrictions for birth years (since tic disorders tend to start 
early in life) or psychiatric comorbidity. 
All individuals were followed from their 6th birthday (study V), the date of birth (study VI), or 
January 1, 1973 (both studies), until the date of a diagnosis of a metabolic or cardiovascular 
disorder, emigration, death, or end of follow-up on December 31, 2013, when no more 
information was available from the Swedish National Registers. 
 
4.3 DATA SOURCES 
4.3.1 Structured literature search (study I) 
For study I, we performed a structured literature search in three medical databases, namely 
PubMed, Embase, and Scopus, using keywords and Medical Subject Heading (MeSH) terms. 
The search terms covered both general risk factors and a priori defined specific areas that, 
based on the literature, were suspected likely candidates, including perinatal events (e.g., birth 
complications, birth weight, gestational age, parental and family factors, season of birth), 
reproductive cycle events (including menarche, pregnancy, postpartum, and menopause), 
parental rearing styles, stressful life events (e.g., childhood trauma, amount of life events, 
traumatic life events), socioeconomic status, infections, traumatic brain injury, substance 
abuse, vitamin deficiency, famine, immigration, adoption, and urbanization. The search 
included all papers published from inception until October 6, 2015. Reference lists were also 
examined for relevant papers to supplement the search. 
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4.3.2 The Swedish national registers and the personal identification 
numbers 
Data for studies II-VI were obtained by linking information from Swedish national registers 
through the unique personal identification numbers (PIN) assigned to all Swedish citizens at 
birth or immigration.92 The linkage was performed by the National Board of Health and 
Welfare where the PINs were replaced by randomly assigned sequential numbers before the 
data was delivered. Each of the relevant registers will be briefly described here. 
 
4.3.3 The Total Population Register 
The Total Population Register contains demographic information (e.g., sex, birth date, family 
relationships, migration) on all Swedish inhabitants since 1968. The Total Population Register 
is also used to construct the Migration Register and the Multi-Generation Register. 
The Migration Register contains information about emigration since 1961 and immigration 
since 1969 from and to Sweden.93 The Multi-Generation Register connects every person born 
in Sweden since 1932, and ever registered as living in Sweden from 1961, with their parents, 
both biological and adoptive. This allows for identifying relatives of different genetic 
relatedness, such as siblings. The register contains information on 100% of mothers and 98% 
of fathers of individuals born after 1961.94 
 
4.3.4 The National Patient Register 
The NPR covers all primary medical diagnoses and up to eight additional diagnoses given from 
inpatient hospital admissions since 1969, with diagnoses based on the International 
Classification of Diseases (ICD), eighth (ICD-8; 1969–1986), ninth (ICD-9; 1987–1996), and 
tenth (ICD-10; 1997–2013) revisions. All counties in Sweden started recording psychiatric care 
from 1973 and from 2001 outpatient specialist care is also included.95 
 
4.3.5 The Medical Birth Register 
The Swedish Medical Birth Register includes data on more than 99% of all pregnancies and 
deliveries in Sweden since 1973. The register is constructed based on information from 
Medical Birth Reports, which are summarized medical records on a standard form prepared by 
secretaries at obstetric clinics. From 1982, an updated form is used, concentrating on antenatal 
care of the mother, the delivery record, and the record for the pediatric examination of the 
newborn. At the same time, the contents of the register were expanded and for some categories, 
check boxes were introduced instead of medical codes.96 
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4.3.6 Other registers 
The Prescribed Drug Register contains data on all dispensed prescriptions of medication to the 
whole population of Sweden since July 1, 2005. The information includes type of medication 
classified according to the Anatomical Therapeutic Chemical (ATC) classification system, date 
of the prescription, and dosage. It does not include information on indication for treatment.97 
The Cause of Death Register includes dates and causes of more than 99% of all deaths of 
Swedish residents, both in Sweden and abroad, since 1961.98 
 
4.4 MEASUREMENTS 
4.4.1 Systematic review (study I) 
For each one of the eligible studies to be included in the systematic review, a number of 
variables were extracted, including sample size, nature of the sample (e.g., clinical sample, 
population cohort), study design (e.g., case-control, cross-sectional), diagnostic procedures, 
outcome measures, and relevant results. 
 
4.4.2 OCD and tic disorder diagnoses in the observational studies 
For all register-based studies contained in this thesis (studies II-VI), OCD and/or tic disorders 
constituted either the exposure or the outcome variable. The NPR was used to identify all 
individuals with either disorder (or both) by their diagnostic codes using the ICD-8, ICD-9, and 
ICD-10 classificatory systems (Table 1). 
 
Table 1. ICD codes for obsessive-compulsive disorder and tic disorders 
Disorder ICD-8 codes ICD-9 codes ICD-10 codes 
Obsessive-compulsive disorder 300.3 300D F42 
Tourette syndrome  and tic 
disorders 
306.2 307C F950: Transient tic disorder 
F951: Chronic motor or vocal tic disorder 
F952: Tourette syndrome 
F958: Other tic disorders 
F959: Unspecified tic disorder 
 
The quality of the results of these studies relies completely on the validity of the variables in 
the registers. To that end, it is imperative that validation studies are performed. The diagnostic 
codes for OCD and tic disorders in the NPR have, prior to the studies in this thesis, been 
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validated.99 The validation process was performed by chart review. Complete medical records 
of 100 randomly selected OCD cases and 100 randomly selected tic disorder cases (based on 
ICD-8, ICD-9, and ICD-10 definitions) were requested from three different Swedish counties 
(Stockholm, Södermanland, and Gotland). For every other case with a tic disorder, a control 
with a registered epilepsy diagnosis was also randomly selected, and for every other case with 
OCD, a control with major depression was selected. Two blinded psychiatrists independently 
performed the chart review of the complete medical records of all cases and controls. 
The positive predictive value (PPV; correctly diagnosed cases divided by the sum of true 
positives and false positives) of OCD was 0.71-0.72, with a Cohen’s κ inter-rater reliability of 
0.98. Similar results have been produced by a Danish study of 100 children with early-onset 
OCD, finding a PPV of 0.85.100 However, Rück et al.99 found unacceptably high rates of false 
positives in OCD diagnosed with ICD-8 and ICD-9 codes. It was recommended that mainly 
ICD-10 codes were used in OCD research using the Swedish NPR. 
Based on the recommendations by Rück et al.,99 OCD was defined as a registered ICD-10 
diagnosis in study II. In studies IV and V, ICD-8 and ICD-9 codes for OCD were also included 
to maximize the OCD cohort size and statistical power, but sensitivity analyses including ICD-
10 codes only were performed. 
For tic disorder codes, the validity was excellent, with a PPV of 0.92 and Cohen’s κ of 1. 
This corresponds well with a Finish chart review performed on the medical records of 88 
children diagnosed with Tourette, finding a validity of 95%.101 However, when Rück et al.99 
contrasted different forms of tic disorders against each other, there was less consistency, 
clinicians seemingly using the codes for Tourette syndrome and of chronic tic disorder 
interchangeably. For this reason, studies from our research group cannot separate Tourette 
syndrome from chronic tic disorder, a distinction that has equally been questioned in the 
literature.102 Rück et al.99 proposed an algorithm to ensure that only chronic tic disorders were 
used in research, and was aimed at excluding individuals with transient tic disorders and 
ascertain whether individuals with other tic disorders or unspecified tic disorder indeed were 
chronic or not. 
The algorithm for tic disorders suggested by Rück et al.99 was employed in studies III and VI. 
In study IV, any registered tic disorder diagnosis was used in accordance with the description 
of the tic-related specifier to OCD in DSM-5, which does not specify that tics need to be 
chronic.1 
 
4.4.3 Perinatal risk factors (studies II & III) 
In studies II and III, the associations between several adverse perinatal events and OCD or tic 
disorders were examined. As described above, the NPR was used to identify OCD and tic 
disorders cases (outcomes). The Medical Birth Register was used to identify adverse perinatal 
events (exposures). The perinatal events in focus were maternal smoking during pregnancy, 
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labor presentation, obstetric delivery, gestational age, birth weight, birth weight in relation to 
gestational age, Apgar score at 5 minutes, and head circumference. 
 
Maternal smoking during pregnancy 
When the Medical Birth Reports were updated in 1982, maternal smoking during pregnancy 
was introduced as a variable. Therefore, this variable was examined only in individuals born 
from 1982 onwards, thereby reducing the size of the birth cohorts in both studies for this 
category. The information on maternal smoking is collected at the first antenatal care visit and 
is a categorical variable with three levels: no daily smoking, 1 to 9 cigarettes per day, and more 
than 10 cigarettes per day. 
 
Labor presentation 
Labor presentation was divided into three categories: normal presentation, breech presentation, 
and other malpresentation (e.g., face or brow presentations, transverse lie). The proportion of 
unknown labor presentations has varied greatly over time in the Medical Birth Register. 
However, the number of various non-normal presentations has remained fairly stable, 
suggesting that the majority of unknown presentations were likely normal presentations.96 To 
avoid introducing bias by making assumptions, unknown presentations were handled as 
missing values. 
 
Obstetric delivery 
Delivery method is recorded in the Medical Birth Report as spontaneous vaginal, forceps, 
vacuum extraction, or cesarean section.96 To increase power, delivery by forceps or vacuum 
extraction were collapsed into a single variable: assisted (instrumental) vaginal delivery. At 
inspection of the database, it was noted that these three categories were not mutually exclusive 
in the Medical Birth Register, and they were therefore hierarchically ordered. If there was a 
record of cesarean section, that was prioritized, if not, assisted delivery was prioritized, and 
otherwise recorded vaginal delivery was used. Where no information was recorded and method 
of delivery was unknown, the value of the variable was set to missing (despite the fact that, as 
with labor presentation, most missing values were likely unassisted vaginal deliveries). 
 
Gestational age 
In the Medical Birth Register, pregnancy duration is estimated combining the date of the last 
menstrual period, the estimated date of delivery, the corrected estimated date of delivery based 
on second-trimester ultrasound, and information on pregnancy duration from the pediatric 
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record.96 In study II, examining the association between gestational age and OCD, gestational 
age was divided into four categories: very preterm birth (<32 weeks), preterm birth (32-36 
weeks), term birth (37-41 weeks), and postterm birth (≥42 weeks). It was additionally analyzed 
as a continuous variable, including both linear and quadratic terms, distributed as every week. 
Because tic disorders are less common disorders than OCD, the analyses of gestational age 
needed to be adjusted in study III. Instead of four categories, three were used: preterm birth 
(<37 weeks), term birth (37-41 weeks, reference category), and postterm birth (≥42 weeks). 
Since the continuous representation of gestational age served the purpose of further exploring 
the validity of a potential dose-response pattern, it served no purpose to conduct this additional 
analysis in study III, since no dose-response pattern could be extracted from only three 
categories. 
 
Birth weight 
Birth weight was analyzed both as a categorical variable and as a continuous, linear and 
quadratic, variable in both studies II and III. Study II employed six categories, consisting of 
“very low birth weight” (≤1500 g), “low birth weight” (1501-2500 g), 2501-3500 g, “normal 
birth weight” (3501-4500 g, reference category), and “high birth weight” (>4500 g). Due to the 
lower number of tic disorders cases, the “very low birth weight” category needed to be excluded 
in study III. Similar to gestational age, the continuous representation of birth weight served the 
purpose of further examining a potential dose-response pattern. Birth weight is greatly 
associated with gestational age. Therefore, to ensure that a potential association between birth 
weight and either OCD (study II) or tic disorders (study III) was due to an association between 
gestational age and either disorders, all analyses of birth weight were further adjusted by 
gestational age as a continuous variable, both linear and quadratic. 
 
Birth weight in relation to gestational age 
The Medical Birth Register includes two binary variables for small for gestational age and large 
for gestational age. The definition of these variables is two standard deviations below or above 
the mean weight for that gestational week, respectively, based on the Scandinavian fetal growth 
curve, adjusted for sex.103 The association between these two variables and OCD (study II) and 
tic disorders (study III) was analyzed as an addition to gestational age and birth weight. 
 
Apgar score at 5 minutes 
The Apgar score is a convenient tool to determine the general health of newborn infants, 
generally stated at 1 minute, 5 minutes, and 10 minutes after birth. It is comprised by five 
indicators, rated 0 to 2, chosen because they can be easily determined without interfering with 
the care of the infant.104 The indicators and scores are listed in Table 2 below. 
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Table 2. List of Apgar items and scores 
Indicator Score 0 Score 1 Score 2 
Appearance / 
complexion 
Blue or pale all over Blue at extremities, body 
pink 
No cyanosis, body and 
extremities pink 
Pulse rate Absent <100 >100 
Grimace / reflex 
irritability 
No response to 
stimulation 
Grimace / feeble cry when 
stimulated 
Cry or pull away when 
stimulated 
Activity None Some flexion Flexed arms and legs that 
resist extension 
Respiration / respiratory 
effort 
Absent Weak, irregular, gasping Strong, lusty cry 
 
For each time interval, there is an increasing proportion of missing values for Apgar scores in 
the Medical Birth Register. The higher the total score at the preceding rating, the higher 
proportion of missing values for the succeeding one, suggesting that the majority of missing 
values are due to normal scores.96 Apgar at 5 minutes was chosen for studies II and III to capture 
deteriorating health status after birth, while at the same time not losing too many cases to 
missing values. It was not assumed that missing values were normal, but remained missing in 
the analyses. The scores were divided into three categories in study II, in accordance with 
neonatal practice: normal (score of ≥7), distress (4-6), or near death (≤3).105 Due to lower 
power, only two categories were used in study III: normal (score of ≥7) or abnormal (<7). 
 
Head circumference 
Head circumference is recorded in centimeters in the Medical Birth Register. Based on 
categories established according to the World Health Organization standards,106 this 
information was converted into a categorical variable with three levels. For birth at every 
gestational week, small head circumference was defined as a head circumference below the 
10th percentile whereas large head circumference above the 90th percentile. 
 
4.4.4 Tic-related OCD (study IV) 
Study IV examined the risk of OCD in relatives of individuals with OCD with versus without 
comorbid tics, compared to relatives of unaffected individuals. The NPR was used to identify 
all individuals with a lifetime diagnosis of OCD. Among them, everyone with a lifetime 
diagnosis of a tic disorder, in addition to OCD, was identified. A lifetime OCD diagnosis, with 
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or without a tic disorder diagnosis, constituted the exposures, and the first date of a recorded 
OCD diagnosis in the relative, independent of a tic diagnosis, constituted the outcome.  
 
4.4.5 Metabolic and cardiovascular outcomes (studies V & VI) 
Study V examined the association between OCD and metabolic and cardiovascular disorders, 
and study VI the association between tic disorders and metabolic and cardiovascular disorders. 
The metabolic syndrome refers to a cluster of risk factors associated with cardiovascular 
disease and type 2 diabetes mellitus. The cluster includes abdominal obesity, increased 
triglyceride levels, reduced high-density lipoprotein cholesterol levels, high blood pressure, 
and hyperglycemia.107 The metabolic syndrome does not have a dedicated ICD code. Instead, 
medical conditions associated with the criteria for metabolic syndrome were used as proxies. 
Type 2 diabetes mellitus and cardiovascular diseases were additionally included because of 
their strong association with the metabolic syndrome. Obesity, hypertension, type 2 diabetes 
mellitus, and cardiovascular diseases were identified through their ICD codes in the NPR. To 
additionally capture those only diagnosed and followed up in primary care, individuals with 
specific medications prescribed for dyslipidemia, hypertension, and type 2 diabetes mellitus 
were identified in the Prescribed Drug Register (Table 3). Since the medications to treat 
cardiovascular diseases and hypertension generally overlap, and could therefore not be 
meaningfully separated from each other, these disorders were combined under the term 
circulatory system diseases, following the ICD nomenclature for the group including these 
conditions. Individuals with recorded diagnoses of both type 2 diabetes mellitus and type 1 
diabetes mellitus were excluded, to avoid confounding from an etiologically distinct condition. 
In individuals with both a registered ICD diagnosis and a corresponding registered drug 
prescription, the earliest of date was used as censoring date in the survival analysis.  
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Table 3. Correspondence between the harmonized definition of the metabolic syndrome107 and the selected metabolic 
and cardiovascular disorders and drug prescriptions for such disorders used as proxy in the current study 
Criteria for clinical diagnosis of the metabolic 
syndrome107 
Metabolic and 
cardiovascular disorders 
from the Swedish 
National Patient Register 
Drug prescriptions for 
metabolic and cardiovascular 
disorders from the Swedish 
Prescribed Drug Register 
Measure Categorical cut points 
Elevated waist 
circumference [it is 
recommended that the IDF 
cut points be used for non-
Europeans and either the 
IDF or AHA/NHLBI cut 
points used for people of 
European origin until more 
data are available]  
Population- and country-
specific definitions  
Obesity [ICD-8 code 277; 
ICD-9 codes 278.0/.1; ICD-
10 code E66]  
– 
Elevated triglycerides (drug 
treatment for elevated 
triglycerides is an alternate 
indicator)  
≥150 mg/dL (1.7 mmol/L)  – Lipid modifying agents, plain 
[ATC code C10A]  
Reduced HDL-C (drug 
treatment for reduced HDL-
C is an alternate indicator)  
<40 mg/dL (1.0 mmol/L) in 
males; <50 mg/dL (1.3 
mmol/L) in males  
– Lipid modifying agents, plain 
[ATC code C10A]  
Elevated blood pressure 
(antihypertensive drug 
treatment in a patient with a 
history of hypertension is 
an alternate indicator)  
Systolic ≥130 and/or 
diastolic ≥85 mm Hg  
Hypertension [ICD-8 codes 
400-404; ICD-9 codes 401-
405; ICD-10 codes I10-15]  
Antihypertensives [ATC code 
C02] (In study VI clonidine (ATC 
code C02AC01) and guanfacine 
(ATC code C02AC02) were 
excluded due to these drugs 
being prescribed for tic disorders)  
Diuretics [ATC code C03]  
Beta blocking agents [ATC code 
C07]  
Calcium channel blockers [ATC 
code C08]  
Agents acting on the renin-
angiotensin system [ATC code 
C09]  
Elevated fasting glucose 
[most patients with type 2 
diabetes mellitus will have 
the metabolic syndrome by 
the proposed criteria] (drug 
treatment of elevated 
glucose is an alternate 
indicator)  
≥100 mg/dL  Type 2 diabetes mellitus 
[ICD-10 code E11], but not 
type 1 diabetes mellitus 
[ICD-10 code E10]  
Blood glucose lowering drugs, 
excluding insulins [ATC code 
A10B], but not Insulins and 
analogues [ATC code A10A]  
– – Ischemic heart diseases 
[ICD-8 codes 410-414; 
ICD-9 codes 411-414; ICD-
10 codes I20-25]  
Arrhythmia [ICD-8 codes 
427-429; ICD-9 codes 426-
429; ICD-10 codes I44-49]  
Cerebrovascular diseases 
and transient ischemic 
attack [ICD-8 codes 430-
438; ICD-9 codes 430-437; 
ICD-10 codes I60-66 and 
G45]  
Arteriosclerosis [ICD-8 
codes 440-444; ICD-9 
codes 440-444; ICD-10 
codes I70-74]  
Cardiac therapy [ATC code C01]  
Antihypertensives [ATC code 
C02]  
Diuretics [ATC code C03]  
Peripheral vasodilators [ATC 
code C04]  
Vasoprotectives [ATC code C05]  
Beta blocking agents [ATC code 
C07]  
Calcium channel blockers [ATC 
code C08]  
Agents acting on the renin-
angiotensin system [ATC code 
C09]  
Abbreviations: AHA/NHLBI American Heart Association/National Heart, Lung, and Blood Institute; ATC Anatomical Therapeutic 
Chemical Classification System; HDL-C High-Density Lipoprotein Cholesterol; ICD International Classification of Diseases; IDF 
International Diabetes Federation. 
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Prolonged use of psychiatric medication has been linked to the risk for metabolic syndrome.87 
Therefore, we explored the impact of psychiatric medication on the risk for metabolic and 
cardiovascular disorders in OCD and tic disorder patients. The information on the use of 
medication was retrieved from the Prescribed Drug Register, which is limited to July 2005 
through December 2013. For OCD, the impact of the antidepressant medication family SRIs, 
with or without additional antipsychotic medication, was examined, and for chronic tic 
disorders, antipsychotic medication. 
 
4.4.6 Covariates 
In all observational studies, there are factors that are suspected to be associated both with the 
exposure and the outcome, thereby confounding potential associations between them. For 
example, in studies II and III, it could be that the age of the mother at the time of birth of the 
offspring might increase the risk of preterm birth and, independently, the risk of OCD or tic 
disorders. In order to examine as much of the true associations as possible, potential 
confounders were adjusted for in all observational studies. 
In studies II and III, we adjusted for the following potential confounders: birth year, sex of the 
infant, parity, and the age of the mother and the age of the father at childbirth. Information on 
all these variables was collected from the Medical Birth Register, except for paternal age at 
childbirth, which was calculated from the date of birth of the father (collected from the Multi-
Generation Register) and date of birth of the infant (collected from the Medical Birth Register). 
In studies IV-VI, birth year and sex were adjusted for; information that was retrieved from the 
Total Population Register. 
 
4.5 STATISTICAL METHODS 
4.5.1 Quality assessment in study I 
In study I, the systematic review could unfortunately not be complemented with a meta-
analysis. The data from the studies included proved too heterogeneous or insufficient to 
conduct comparisons. Therefore, only a qualitative synthesis of the studies was conducted, by 
which characteristics of the samples (e.g., size, selection) and methods (e.g., design, measures) 
were weighted with the reported results. 
 
4.5.2 General statistical methods in studies II-VI 
In studies II-VI, survival analyses were performed to take advantage of the detailed information 
on timing of different events. Survival analyses examine the time it takes for events to occur, 
often comparing the survival times depending on one or more predictors. Everyone not having 
the event contributes to the analysis as comparisons until they are “lost to follow-up” (e.g., 
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migration, death, or end of study period), when there is no more information about them. All 
of the observational studies in this thesis employed Cox proportional hazards regression as the 
main survival analysis method, to estimate hazard ratios (HR) and 95% confidence intervals 
(CI) of the associations between exposure and outcome. HR can essentially be interpreted as 
multiplication of likelihood, where a HR of 2 would be twice as likely, 1.25 would be 25% 
increased likelihood, 1 would be no difference in likelihood, and 0.75 would be a 25% decrease 
in likelihood. Studies II, III, V, and VI applied the same basic quasi-experimental approaches 
to strengthen the observed associations by combining study designs aimed at excluding 
alternative explanations. The designs included: 
• Main analysis (with varying adjustments and/or stratifications) 
• Sibling comparison (to control for shared family confounders) 
• Analyses excluding individuals with comorbid psychiatric disorders (one [or one 
cluster] at a time, to rule out that associations were explained by the presence of 
comorbid disorders) 
 
4.5.3 Statistical methods in studies II and III – perinatal risk factors 
Cox regression was used to estimate HRs and corresponding 95% CI for the association 
between adverse perinatal events and OCD (study II) or tic disorders (study II). In order to 
ascertain that the perinatal events and OCD or tic disorders were not both explained by other 
measured and available factors, so-called confounders, the analysis was run three times: first 
without any adjustments, second adjusting for sex and birth year, and third adjusting for parity 
and age of mother and father at birth of the offspring in addition to sex and birth year. 
To exclude alternative explanations of the associations, we compared full siblings within the 
same family with each other, using stratified Cox regression, thereby controlling for 
confounders shared between full siblings, such as 50% of the genetic liability and shared 
environmental factors like socioeconomic status. These analyses were also adjusted for all 
measured confounders. 
To examine whether other psychiatric disorders mediated (or confounded) the association 
between adverse perinatal events and having OCD or tic disorders, the adjusted Cox regression 
model was run while excluding all individuals with comorbid psychiatric disorders, one [or one 
cluster] at a time.  
 
4.5.4 Statistical methods in study IV – family clustering of tic-related OCD 
In study VI, we used Cox regression to estimate HR, and corresponding 95% CI, for the risk 
of OCD in relatives of individuals with tic-related OCD vs. in relatives of individuals with non-
tic-related OCD, compared to unaffected individuals. This was applied to each sub-cohort, 
namely twins (of any zygosity), full siblings, maternal half siblings, paternal half siblings, and 
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cousins. Birth year and sex were adjusted for in both the exposing and the outcome individuals. 
Because the hypothesis was that the presence of OCD (with or without tics) was a proxy for 
familial factors, lifetime presence was used as exposure. This also meant that the effect was 
analyzed in both directions between a pair of relatives, both potentially exposing each other, 
instead of favoring time-varying exposure where only the first to have a registered diagnosis 
would serve as the exposing individual. Including all possible combinations of pairs and 
directions of effects between them meant that each individual could occur multiple times in the 
analyses. See Table 4 for an example of a family of three full siblings. Cox regression assumes 
independence between observations. However, data within family or individual clusters tend 
to be positively correlated. If this non-independence of clustered data is not addressed, standard 
errors (which are the bases for confidence intervals and statistical significance testing) would 
be underestimated. To correct standard errors to account for the non-independence of clustered 
data, robust standard errors were used, which provided more stringent definitions of statistical 
significance.  
 
Table 4. Example of combinations of associations examined in a family with three siblings 
Exposure individual  Outcome individual 
Sibling 1 à Sibling 2 
Sibling 1 à Sibling 3 
Sibling 2 à Sibling 1 
Sibling 2 à Sibling 3 
Sibling 3 à Sibling 1 
Sibling 3 à Sibling 2 
 
To further investigate the associations, we conducted a series of sensitivity analyses. Tic-
related OCD has been associated with early onset.21,25 In previous studies, early onset OCD, in 
turn, has been associated with increased risk of other family members also having OCD.19,20 It 
might, therefore, be that the early onset of OCD in tic-related OCD is the driving force behind 
it being associated with increased risk of other family members having OCD. To check this 
hypothesis, we matched 5 randomly selected non-tic-related OCD cases to every tic-related 
OCD case by date of first registered OCD diagnosis (± 1 year), excluded all other non-tic-
related OCD cases, and ran the Cox regression model again on these sub-groups. Furthermore, 
because tic disorders are highly heritable neuropsychiatric disorders, it might be that its 
comorbidity with OCD was behind the increasing the risk of OCD in relatives. This would 
suggest that OCD in combination with another heritable neuropsychiatric disorder would also 
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result in an increased likelihood of family members having OCD. To investigate this, we ran 
analyses where we compared OCD cases with comorbid ADHD or autism spectrum disorders 
(ASD) to OCD cases without ADHD or ASD. 
 
4.5.5 Statistical methods in studies V and VI – metabolic and cardiovascular 
disorders 
Cox regression was used to estimate HRs and corresponding 95% CI for the association 
between OCD (study V) or tic disorders (study VI) and metabolic and cardiovascular disorders. 
The main analysis in both studies was the association with any of the a priori defined metabolic 
and cardiovascular disorders, followed by analyses for each separate metabolic or 
cardiovascular disorder. All models were adjusted for sex and birth year. In addition to 
adjusting for sex, the analyses were also stratified by sex, to identify potential difference in risk 
depending on this variable. As above, sibling comparisons were employed to rule out 
alternative explanations. 
Other comorbid psychiatric disorders (or clusters of them) were excluded one at a time and the 
Cox regression run again, to ascertain that associations were not explained in full by or 
completely dependent on the presence of other disorders. 
Since the cohorts were based on everyone living in Sweden in 1973 or later, there was a 
proportion of the cohort with unknown events before 1973. For this reason, the main Cox 
regression model was run on subgroups of the cohorts, consisting of everyone with complete 
follow-up from age 6 in study IV and from birth in study V. Additionally, in study IV, the main 
analysis was run including only OCD defined by ICD-10 codes, since validity for the ICD-8 
and ICD-9 codes is poor.99 
To examine whether associations between OCD or chronic tic disorders and metabolic and 
cardiovascular disorders were better explained by the use of long-term medication, we 
conducted exploratory analyses to examine the risk of metabolic and cardiovascular disorders 
in OCD or chronic tic disorders, depending on the use of psychotropic medication. We used 
cumulative time-varying exposure to determine duration of medication, and divided the 
duration into categories. In study IV, both duration and dosage were divided into categories (in 
≤1 year, 1-3 years, >3 years, and small doses or occasional use, moderate doses, and high doses, 
respectively), creating nine categories compared to the tenth category of ‘no SRI medication’. 
These categories were further stratified into with or without additional antipsychotic 
medication. Since tic disorders are less common than OCD, the small sample of chronic tic 
cases was prohibitive of the same categorization. Instead, only duration was used and 
categorized as ≤1 year and >1 year, compared to no antipsychotic medication.  
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5 RESULTS 
5.1 SYSTEMATIC REVIEW OF ENVIRONMENTAL RISK FACTORS FOR OCD 
(STUDY I) 
Study I systematically summarized the results from all previously published papers on a broad 
range of environmental risk factors for OCD. The initial search from the three selected 
databases identified a list of 9,950 potentially relevant papers. Of these, 3,415 proved to be 
duplicates and were removed. The remaining papers were first screened on title and abstract, 
before full text assessments were performed. Ultimately, 128 papers were included in the 
qualitative synthesis, 12 of which were identified from reference lists. The heterogeneity and 
the insufficiency of the data collected from the included papers unfortunately precluded 
conducting a meta-analysis. Instead, a qualitative synthesis of the studies was performed. 
The findings indicated that birth complications in general, and specific complications, such as 
low birth weight, delivery by forceps, and protracted labor, had been previously linked to OCD. 
The results for other birth and family related factors (such as season of birth, family size, and 
birth order) appeared to be either conflicting or not supported. 
On the other hand, reproductive cycle events (e.g., menarche, pregnancy, and postpartum) 
appeared to increase risk for OCD and for exacerbated obsessive-compulsive symptoms in 
women. However, there have also been reports of ameliorated obsessive-compulsive 
symptoms during pregnancy and postpartum. 
Several studies reported that patients with OCD associate the onset of the disorder with stressful 
or traumatic life events. Associations were found between OCD and stressful life events in 
general, increased amount of life events, and traumatic life events (with or without post-
traumatic stress disorder) in both adulthood and childhood, including sexual abuse, physical 
abuse, and verbal or emotional abuse. However, some studies examining stressful or traumatic 
life events did not find any association. Nonetheless, hypothetically, individuals with OCD 
may be more prone to recall negative events and connect them to their OCD onset. 
The most extensively researched association between OCD and infections has been that with 
autoimmune dysfunction caused by the group-A beta-hemolytic streptococcal infections 
(GABHS), leading to the clinical presentation known as Pediatric Autoimmune 
Neuropsychiatric Disorder Associated with Streptococcal Infections (PANDAS).108 The 
clinical characteristics of PANDAS differ from classic OCD in that it has a sudden onset in 
prepubertal age, a relapsing-remitting course, temporal association with GABHS, and 
neurological abnormalities. However, only a few of the studies trying to find associations 
between OCD and GABHS actually found positive associations.   
Additionally, parental rearing styles, socioeconomic status, brain injury, substance use 
disorders, and vitamin deficiency have been researched to a varying extent. Studies have 
reported either no associations or too conflicting results to draw any firm conclusions from. 
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The majority of the papers included in the systematic review suffered from important 
methodological limitations, including small clinic-based samples and retrospectively collected 
data. 
 
5.2 PERINATAL RISK FACTORS (STUDIES II & III) 
Study II used a cohort consisting of 2,421,284 individuals, of which 17,305 had a recorded 
OCD diagnosis in the NPR. From this cohort, 743,885 families with at least two full siblings 
were identified for the full sibling comparison. In study III, 3,026,861 individuals were 
included, of which 5,597 had a record of a tic disorder diagnosis in the NPR. For the full sibling 
comparison, 947,942 families with at least two siblings were identified. This difference in 
sample size was a consequence of only including individuals born in 1996 or earlier in study II 
and in 2007 or earlier in study III, the reason being the earlier onset of tic disorders and wanting 
all individuals to have sufficient time to have a diagnosis registered. 
An overall pattern emerged whereby adverse perinatal events were associated with increased 
risk of both OCD and tic disorders. For OCD, those not better explained by shared family 
factors included mothers smoking 10 or more cigarettes per day during pregnancy, breech 
presentation, cesarean section, low birth weight, preterm birth, large for gestational age, and 
Apgar distress scores. For tic disorders, especially impaired fetal growth, as represented both 
by low birth weight and small for gestational age, was robust when shared family factors were 
taken into account. Additionally, the risk estimates for breech presentation, cesarean section, 
and preterm birth remained when shared family factors were accounted for. A summary of the 
most important results from the fully adjusted models in both disorders is presented in Table 
5. 
The continuous representations showed that the lower the birth weight, the higher the risk of 
OCD and tic disorders, and the shorter the gestational age, the higher the risk of OCD, lending 
additional support to the dose-response nature of the associations observed in the categorical 
analyses of birth weight and gestational age. 
Additionally, we found that perinatal complications cumulatively contribute to the risk of both 
OCD and tic disorders, in that the greater the number of adverse perinatal events, the higher 
the risk for the disorders (illustrated in Figure 2) 
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Table 5. Adverse perinatal events and risk of OCD (study II) or tic disorders (III). All the results remained in the 
subsequent sibling comparison analysis unless otherwise specified 
Perinatal event Risk of OCD in the offspring (study II) Risk of tic disorders in the offspring 
(study III) 
Maternal smoking during pregnancy 1-9 cigarettes/day was associated with 
a 6% increased risk1 
≥10 cigarettes/day was associated with 
a 20% increased risk 
1-9 cigarettes/day was associated with 
a 40% increased risk1 
≥10 cigarettes/day was associated with 
a 88% increased risk1  
Labor presentation Breech presentation was associated 
with a 26% increased risk 
Breech presentation was associated 
with a 17% increased risk2 
Obstetric delivery Cesarean section was associated with a 
9% increased risk 
Assisted vaginal delivery was 
associated with a 12% increased risk2 
Cesarean section was associated with 
a 22% increased risk1 
- 
Gestational age Very preterm birth was associated with 
a 61% increased risk2 
Preterm birth was associated with a 
20% increased risk 
N/A3 
 
Preterm birth was associated with a 
25% increased risk2 
Birth weight Low birth weight was associated with a 
10% increased risk 
High birth weight was associated with a 
17% increased risk2 
Low birth weight was associated with a 
26% increased risk2 
- 
Small for gestational age 10% increased risk2 49% increased risk 
Large for gestational age 20% increased risk - 
Apgar score at 5 minutes Distress scores were associated with a 
28% increased risk 
Near death scores were associated with 
a 40% increased risk2 
- 
 
- 
Small head circumference 7% increased risk1 31% increased risk1 
1 The results did not remain in the sibling comparison 
2 The results did not remain statistically significant in the sibling comparison, but the estimates remained approximately the same 
3 This level of the variable was not included in study III 
 
 
Figure 2. Association between number of adverse perinatal events and OCD or tic disorders, expressed as hazard 
ratios and 95% confidence intervals 
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In general, excluding individuals with comorbid psychiatric disorders one (or one cluster) at a 
time from the analysis attenuated some estimates and reduced precision, but did not indicate 
that the presence of these disorders explained the associations between the adverse perinatal 
events and OCD or tic disorders. 
 
5.3 FAMILY CLUSTERING OF TIC-RELATED OCD (STUDY IV) 
A total of 4,085,367 individuals were included in the birth cohort for study VI. Of these 1,257 
had tic-related OCD and 20,975 had non-tic-related OCD. Tic-related OCD was defined as the 
combination of both a lifetime OCD diagnosis and a lifetime tic disorder diagnosis. 
The estimated risk of OCD in relatives of individuals with OCD increased proportionally to 
the degree of genetic relatedness in both groups, compared to relatives of individuals without 
OCD, indicating that OCD is a familial disorder, regardless of tic disorder status. However, the 
estimates were higher across most types of relatives of individuals with tic-related OCD 
(Figure 3). Furthermore, twins, full siblings, and maternal half siblings of individuals with tic-
related OCD were more than twice as likely to have OCD, compared to the same relatives of 
non-tic-related OCD. 
 
Figure 3. Hazard ratios (95% CIs) of OCD in relatives of individuals with OCD, stratified by tic disorder status, 
compared to unaffected population. P-values for hazard ratios between OCD groups 
 
Matching the OCD cases by age at first diagnosis did not significantly change the results from 
the main model, with consistently higher estimates for relatives of individuals with tic-related 
OCD. 
The same pattern of increased risk of OCD in relatives of individuals with tic-related OCD was 
not observed when, instead of tic disorders, co-occurring ADHD or ASD was used.  
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5.4 METABOLIC AND CARDIOVASCULAR DISORDERS (STUDIES V & VI) 
The total population cohort for study V included 12,497,002 individuals, of which 25,415 had 
a recorded OCD diagnosis. Furthermore, 2,583,209 families with at least two full siblings were 
identified from the complete cohort for sibling comparisons. For study VI, the total population 
cohort consisted of 14,045,026 individuals, of which 7,804 had a recorded tic disorder. From 
these 14 million people, 2,675,482 families with at least two siblings were identified for sibling 
comparisons.  The difference in sample sizes was due to stricter exclusion criteria in study V, 
consisting of excluding individuals dying or emigrating before age 6 (because having an OCD 
diagnosis before then is unlikely) and individuals with psychiatric disorders that are known to 
be medicated with antipsychotic medication (i.e., organic brain disorder, psychotic disorder, 
bipolar disorder, pervasive developmental disorder, Tourette syndrome, chronic tic disorders), 
which in turn has been associated with metabolic syndrome.87 
Both tic disorders and OCD were associated with an increased risk of metabolic and 
cardiovascular disorders in general, and specifically with an increased risk of obesity, type 2 
diabetes mellitus, and circulatory system diseases. In general, the risks were much larger for 
tic disorders than for OCD. For example, the risk of having any metabolic or cardiovascular 
disorder was increased by 45% in individuals with OCD, compared to unaffected individuals, 
whereas the same risk in individuals with tic disorders was increased by 99%. 
When we adjusted for unmeasured familial confounding in the sibling comparison models, we 
found that the risk of metabolic and cardiovascular disorders in individuals with OCD remained 
virtually the same. By contrast, for tic disorders, the risk was considerably reduced in the 
sibling comparison (from 99% increased risk to 37% for any metabolic and cardiovascular 
disorder). The main results from the fully adjusted models are summarized in Table 6. 
 
Table 6. Risk of metabolic and cardiovascular disorders in individuals with OCD (study V) or tic disorders (study VI). 
All the results remained in the subsequent sibling comparison analysis unless otherwise specified 
Metabolic and cardiovascular 
disorders 
Individuals with OCD (study V) Individuals with tic disorders (study 
VI) 
Risk of any complication 45% increased risk 99% increased risk 
Risk of obesity 63% increased risk 176% increased risk 
Risk of dyslipidemia No association in main model, but a 
22% increased risk in the sibling 
comparison 
- 
Risk of type 2 diabetes mellitus 22% increased risk 67% increased risk1 
Risk of circulatory system diseases 44% increased risk 76% increased risk 
1 The estimate was reduced and did not remain statistically significant in the sibling comparison 
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When individuals with different psychiatric disorders were excluded from the analysis, the 
results remained largely unchanged in both studies. The exception was when individuals with 
ADHD were removed from the analysis of tic disorders and metabolic and cardiovascular 
disorders; the estimate was reduced, but remained statistically significant. 
The exploratory analyses of the effects of medication on the risk of metabolic and 
cardiovascular disorders showed similar results in both studies. In OCD patients, the risk of 
metabolic and cardiovascular disorders was significantly reduced the longer the duration and 
the higher the dose of SRI medication, compared to OCD patients without SRI medication, 
independently of additional antipsychotic medication. In tic disorder patients, being on 
antipsychotic medication for more than one year significantly reduced the risk of metabolic 
and cardiovascular disorders, compared to tic disorder patients without antipsychotic 
medication.  
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6 DISCUSSION 
6.1 SYSTEMATIC REVIEW OF ENVIRONMENTAL RISK FACTORS FOR OCD 
(STUDY I) 
This was the first systematic review conducted to summarize the extensive and varied literature 
on potential environmental risk factors for OCD. The review identified several promising areas, 
particularly perinatal complications, reproductive cycle events in women, and stressful or 
traumatic life events. However, most of the studies included were based on small clinical 
samples and/or retrospective data. Additionally, there has been a substantial heterogeneity and 
inconsistency in the definitions and measurements of the risk factors, prohibiting direct 
comparisons between studies. Therefore, none of these areas have provided enough high 
quality results about true associations for any confident conclusions to be drawn. Conversely, 
it follows from the methodological limitations of the included studies that none of the other 
potential risk factors covered in this review can be ruled out either. 
Since the publication of the systematic review in 2016, further studies have investigated the 
role of environmental risk factors in the etiology of OCD. For example, a recent meta-analysis 
concluded that toxoplasmosis could indeed be a risk factor for the development of OCD109 and 
systemic autoimmune diseases were associated with an 85% increased risk of OCD in a 
Taiwanese population-based study.110 Increased maternal age was associated with a 30% 
increased risk of OCD in a Finnish population.111 Patients with OCD from an outpatient clinic 
exhibited significantly higher scores of childhood adversities, both compared with healthy 
controls and unaffected first degree relatives, especially in emotional abuse and emotional 
neglect.112 A longitudinal twin study reported that stressful life events predicted the 
development of obsessive-compulsive symptoms.113 Lastly, a study of 51 adult survivors of the 
Kosovo war found a prevalence of 35% for OCD,114 which is considerably higher than 2% that 
would be expected in the general population.7 While important and adding to the accumulation 
of results pointing at the potential involvement of stressful life events, maternal age, and 
infections in the development of OCD, these new studies suffer from the same limitations as 
those included in the systematic review.  
In light of the methodological limitations that have dominated the research field, the systematic 
review also proposed a road-map for future studies on the role of environmental risk factors in 
the development of psychiatric disorders in general, and of OCD in particular (illustrated in 
Figure 4). This road-map emphasized the importance of using quasi-experimental study 
designs based on prospectively collected data at the population level. Measured potential 
confounders, decided a priori, should be adjusted for and potentially confounding or mediating 
effects of comorbid psychiatric conditions should be investigated. A combination of study 
designs should be applied to synergize the results and exclude alternative explanations of the 
associations. For example, the family-based study design, including full sibling comparisons, 
is a convenient method to control for confounding factors that are shared at the family level, 
including some genetic factors and unmeasured shared environment. The most robust of the 
family-based designs is the discordant monozygotic twin design, which controls for 100% of 
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the genes and shared environmental factors, including age- and sex-related factors and shared 
prenatal factors. Finally, any robust conclusions cannot be expected to be produced from a 
single study or a single population. It is therefore of critical importance that each finding is 
independently replicated in other populations. 
 
 
Figure 4. Possible roadmap towards the identification of environmental risk factors in the causal pathway to OCD 
 
This was the first systematic review conducted to synthesize the literature of environmental 
risk factors for OCD. While no environmental risk factors could be confidently established, the 
study identified the methodological limitations permeating the field and proposed research 
strategies to overcome them. 
 
6.2 PERINATAL RISK FACTORS (STUDIES II & III) 
With up to 40 years of follow-up, studies II and III found that several adverse perinatal events 
were associated with increased risk for both OCD and tic disorders. In the fully adjusted 
models, both disorders were associated with maternal smoking during pregnancy, breech 
presentation, caesarean section, preterm birth, low birth weight, small for gestational age, and 
small head circumference. OCD was additionally associated with assisted vaginal delivery and 
distress and near death Apgar scores at 5 minutes. Dose-response associations between birth 
weight and both OCD and tic disorders and between preterm birth and OCD further supported 
the associations. The magnitude of the associations was similar across disorders, but estimates 
were less precise in tic disorders, due to the lower power. In parallel, knowledge on the genetic 
basis of both disorders will continue to improve and it may be possible to understand how 
genetic and environmental risk factors interact or correlate to increase the risk to both disorders.  
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The results are in line with previous research on both OCD115-121 and tic disorders.122-128 
However, these previous studies were methodologically limited by often small, clinically-
based samples and retrospectively collected data. Additionally, these studies did not control for 
family confounders, something study II and III addressed in full sibling comparisons. The 
associations between most adverse perinatal events and OCD remained significant in the 
sibling comparison, except for small head circumference, for which the association 
disappeared, and assisted vaginal delivery and small for gestational age, where the estimates 
remained approximately the same, but were statistically non-significant. Conversely, in tic 
disorders, only the associations between tic disorders and small for gestational age and birth 
weight of 2501-3500g remained in the sibling comparison. The estimates of the other 
associations remained approximately the same, but lost statistical significance, likely due to the 
lower power in the sibling comparison. The two exceptions were maternal smoking during 
pregnancy and small head circumference, where the associations disappeared in the sibling 
comparison. 
These results are in line with previous research where higher risk of psychotic or bipolar 
disorders, ASD, and ADHD has previously been associated with preterm birth,129 low birth 
weight,130,131 and birth complications.132,133 Previous quasi-experimental studies have provided 
results showing that the associations between maternal smoking during pregnancy and various 
psychiatric disorders and other adverse outcomes are better explained by familial 
confounding,134,135 in line with our findings on tic disorders. It is therefore of particular interest 
that the association between mothers smoking more than 10 cigarettes per day during 
pregnancy and OCD in the offspring remained significant in the full sibling comparison. It is 
thus clear that, while adverse perinatal events are not specific risk factors for OCD and tic 
disorders and they seem to increase the vulnerability or susceptibility for many psychiatric 
disorders, the exception being maternal smoking during pregnancy which as this point has only 
been associated with increased risk of OCD independent of familial confounding. A specific 
limitation of the variable for maternal smoking during pregnancy in the Medical Birth Register 
is that it is self-reported at the first antenatal care visit, therefore more objective measurements 
are needed to confirm these findings. High levels of cotinine (which is metabolized in the liver 
from nicotine) in blood samples of mothers during pregnancy have recently been associated 
with increased risks of ADHD and schizophrenia in offspring.136,137 Thus, in order to confirm 
maternal smoking during pregnancy as a risk factor for OCD, cotinine levels in mothers should 
be examined, preferably supplementing the design with a sibling comparison analysis. 
A biological pathway between adverse perinatal events and OCD and tic disorders has not been 
established. Adverse fetal environments or insults (e.g., hypoxia-ischemia, white matter injury, 
reduced blood flow, malnutrition, differences in development of the serotonergic system) have 
been observed to affect brain development.138-140 Similarly, the fetal programming hypothesis 
posits that the adaptation to the fetal environment may lead to adverse effects in life.141,142 It 
also has been shown that variations in fetal growth are associated with brain development well 
into childhood and adolescence.140,143 In recent years, the gut microbiota has been linked to 
brain function and behavior, including neuropsychiatric disorders.144 Contact with the maternal 
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vaginal and intestinal flora at delivery has been suggested to be important for the development 
of the infant’s gut flora.145 Delivery by cesarean section may thus impair the development of 
the microbiota and consequently represent a pathway to the development of psychiatric 
disorders. This would also imply that elective cesarean section would represent an increased 
risk equal to that of emergency cesarean sections, a theory recently supported in a meta-analysis 
finding that elective and emergency cesarean sections were associated with virtually identical 
risks of ADHD and ASD.146 
These studies contribute new knowledge about the etiology of OCD and tic disorders. Future 
studies are needed to replicate these findings in other populations. There are also many more 
adverse perinatal events not covered in these studies, such as prolonged labor and maternal 
infections that need to be examined. Cesarean section should be studied in more detail to get a 
better understanding of whether elective cesarean section represents less of a risk for 
subsequent psychiatric disorders than emergency cesarean sections, or whether the procedure 
itself (e.g., by means of being unexposed to the gut microbiome) represents an increased risk. 
Additionally, dose-response associations were observed for the total number of adverse 
perinatal events in both OCD and tic disorders, whereby the greater the number of events, the 
greater the risk. This cumulative effect suggests that in the future it may be feasible, once a 
fuller picture of environmental risk factors emerges, to calculate an ‘environmental risk score’ 
for OCD and tic disorders, similar to what has recently been attempted for psychotic 
disorders.147 
Taken together, the results suggest that reducing adverse perinatal events could also reduce the 
risk or even prevent the development of OCD and tic disorders. Amongst all perinatal factors 
identified, the most plausible targets for prevention work are maternal smoking during 
pregnancy and, potentially, the use of unnecessary (i.e., elective) cesarean sections.  
 
6.3 FAMILY CLUSTERING OF TIC-RELATED OCD (STUDY IV) 
The heterogeneity of OCD may be obstructing progress of identifying etiological factors and 
treatment success. By identifying more homogeneous subtypes, or even extract unique 
disorders, future etiological studies, including gene-searching efforts, may be informed and 
treatment approaches may be more individually refined. The proposed subtype of OCD that 
has gained the most support is tic-related OCD.  
Replicating previous findings, OCD was found to be a familial disorder, with risk increasing 
in parallel with genetic relatedness.18,22,38,40 Furthermore, as predicted, the risk of OCD in 
relatives was highest in individuals with tic-related OCD, compared to the risk of OCD in 
relatives of individuals with non-tic-related OCD. 
Using age at first OCD diagnosis as a proxy for age of onset, our data confirmed previous 
reports that tic-related OCD is associated with earlier onset.21,25,26 Early onset OCD has also 
been linked to increased familiality.19,20 Therefore, in order to rule out that the increased risk 
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of OCD in relatives of individuals with tic-related OCD was better explained by the early onset, 
we matched the patients in the tic-related and the non-tic-related OCD groups closely by age 
at first diagnosis. The results remained virtually the same, with the risks being higher in the tic-
related OCD group than the non-tic-related OCD group. 
Another explanation of the increased familiality of tic-related OCD, compared to non-tic-
related OCD, could be that tic disorders are highly heritable by themselves.17,72,148 If that was 
the case, the combination of OCD and another highly heritable disorder would present with the 
same pattern of increased risks. To that end, we ran the main analysis twice, first exchanging 
tic disorders for ADHD and then for ASD. While there was a small, but significant, increase in 
risk of OCD in full siblings of individuals with OCD and ADHD, compared to full siblings of 
individuals with OCD but without ADHD, no other significant differences in risks were 
observed in either ADHD or ASD. These results indicate that the increased familiality of tic-
related OCD is not entirely explained by the comorbidity with another highly heritable 
neuropsychiatric disorder, but is specific to OCD with tic disorders. 
What remains unclear is the nature of tic-related OCD, whether it is quantitatively or 
qualitatively different from OCD (or tic disorders). This cannot be determined from 
observational register data. An approach to investigate this would instead be by means of 
genetic research. However, that would require DNA data from considerable sample sizes of 
both tic-related OCD and non-tic-related OCD. Gene studies have already yielded some results 
of interest in the combination of OCD and tic disorders. No individual genes have been linked 
to either disorder but there is evidence that OCD and tic disorders are genetically correlated 
disorders. 70 At the same time, genome-wide analyses have shown that OCD and tic disorders 
have at least some genetic components that are distinct from each other, and that the underlying 
genetic architecture of OCD may be different depending on the presence of tic disorders.71 
Fortunately, the samples of genotyped individuals with OCD are growing steadily worldwide 
and further progress is to be expected in the not-too-distant future.  
Altogether, this is the first study to provide evidence for a tic-related OCD subtype at the 
population level, confirming the validity of the DSM-5 tic-related OCD specifier, while at the 
same time confirming previous suggestions that tic-related OCD is a more familial subtype of 
OCD. Identifying homogeneous subgroups of OCD may also prove essential for ongoing gene-
searching efforts. 
 
6.4 METABOLIC AND CARDIOVASCULAR DISORDERS (STUDIES V & VI) 
With a follow-up time of more than 40 years and nationwide population cohorts consisting of 
almost 12.5 million individuals in study V and 14 million individuals million individuals in 
study VI, we found that both OCD and tic disorders were associated with increased risks for 
metabolic and cardiovascular disorders. OCD was associated with a 45% increased risk and tic 
disorders were associated with twice the risk of any metabolic and cardiovascular disorder, and 
both disorders were more specifically associated with increased risks for obesity, type 2 
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diabetes mellitus, and circulatory system diseases. The risks were consistently higher in 
individuals with tic disorders, compared to individuals with OCD (non-overlapping confidence 
intervals). Whereas the risks remained the same for OCD in the sibling comparison, the risk 
for tic disorders dropped considerably, indicating either that there are genetic or environmental 
factors affecting both the likelihood of tic disorders and metabolic and cardiovascular disorders 
or that siblings of individuals with tics still have undiagnosed tic disorders, or another 
neuropsychiatric disorder associated with metabolic and cardiovascular disorders.  
Excluding individuals with other psychiatric disorders, one disorder (or one cluster) at a time, 
did not alter the main results considerably; the exception being a reduced, but still significant, 
effect when excluding individuals with ADHD from the tic disorder analysis. However, in that 
analysis, 47% of all tic disorders patients were excluded, and it is thus questionable to what 
extent the remaining 53% are representative of tic disorder patients. Only one naturalistic study 
had previously examined metabolic syndrome and OCD,82 finding a higher prevalence than 
could be expected by chance of metabolic syndrome in the 104 OCD patients. More extensive 
research has been conducted finding increased risks of metabolic syndrome in individuals with 
other psychiatric disorders, such as schizophrenia,78 bipolar disorder,77 and major 
depression.149 
The association between tic disorders and metabolic and cardiovascular disorders has 
previously only been reported as adverse effects of psychiatric medication, especially 
antipsychotics.83-86 The association between psychiatric medication, both antipsychotics and 
antidepressants, and metabolic syndrome has also been reported in other psychiatric conditions, 
such as schizophrenia and depression.87,150-153 These reported associations prompted 
conducting exploratory analyses to investigate whether the increased risks for metabolic and 
cardiovascular disorders in individuals with OCD and tic disorders were mainly due to long-
term medication. Evidence-based treatment includes SRI medication for OCD88 and 
antipsychotic medication for tic disorders.89,90 Therefore, we conducted exploratory analyses 
investigating the association between metabolic and cardiovascular disorders and SRI use, with 
or without antipsychotics, in OCD and antipsychotics use in tic disorders. Contrary to previous 
reports on use of psychiatric medication in other disorders, we found negative associations 
between the use of medication and risk of metabolic and cardiovascular disorders. A similar, 
negative association has previously been observed between the use of antipsychotic and 
antidepressant medication and the risk of mortality in patients with schizophrenia.154 From 
observational data, however, conclusions cannot be drawn about whether these decreased risks 
were due to the medication itself, whether the patients taking medications for OCD and tic 
disorders are inherently different from those not on medication, or whether the regular contact 
with health care professionals provides a better control of their general health and promotes 
healthier lifestyles. 
The biological mechanisms behind the observed associations between OCD or tic disorders 
and metabolic and cardiovascular disorders have so far not been detailed. However, the results 
of the sibling comparison analyses excluded shared family factors, including genetic and 
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environmental factors, as the explanation of the associations. Furthermore, the exploratory 
analyses revealed that long-term medication with SRIs or antipsychotics, did not increase the 
risk of metabolic and cardiovascular disorder further, but, on the contrary, suggested to 
decrease the risk. Taken together, this indicates that the observed increase in risk might largely 
be a functional consequence of the disorders themselves. OCD and tic disorders are highly 
debilitating disorders affecting daily functioning. This, in turn, may influence lifestyle choices 
to include smoking, poor diet, and sedentarism, which has been associated with metabolic and 
cardiovascular disorders.155 This does not, however, preclude other explanations of the 
underlying mechanisms, including shared vulnerability for both OCD or tic disorders and 
metabolic and cardiovascular disorders. For example, in a correspondence letter to study VI, 
another mechanism was suggested involving impaired dopaminergic transmission. Kuhn et 
al.156 noted that tic disorders have been linked to dopaminergic dysfunction and that this in turn 
has been associated with food intake and consequently the homeostatic processes and 
metabolism. Epidemiological studies, such as ours, can only offer limited mechanistic 
explanations but our results generate a number of interesting testable hypotheses. 
The results of studies V and VI have important clinical implications for the management of 
individuals with OCD and tic disorders. In addition to treating the psychiatric disorders, 
emphasis needs to be put on additional lifestyle interventions and carefully monitoring the 
physical health of individuals with OCD and tic disorders with long-term follow-up in order to 
prevent serious health problems and premature death. Future studies should continue mapping 
the long-term health consequences of these disorders as well as replicating these results in other 
populations. The mechanisms behind the increased risk of metabolic and cardiovascular 
disorders in OCD and tic disorders also need further investigating, including the potential role 
of dopaminergic transmission. Family studies could also elucidate the nature of the association 
by exploring the risk of metabolic and cardiovascular disorders in unaffected relatives of 
individuals with either OCD or tic disorders. 
Taken together, while OCD and tic disorders are impairing in their own right, these patients 
are also at an increased risk of adverse long-term health consequences that, so far, have been 
neglected in clinical practice. Measures need to be taken to regularly monitor the physical 
health of these patient groups, and ensure they stay on evidence-based treatment. Furthermore, 
impact of adding lifestyle interventions aimed at reducing cardiovascular risk to the regular 
management of these patients should be evaluated in clinical trials. 
 
6.5 METHODOLOGICAL CONSIDERATIONS 
6.5.1 Register-based research 
Register-based research provides unique opportunities to study phenomena that would 
otherwise have been impossible or too costly to study. Using population-based registers 
provides nearly complete coverage of the entire population, minimizing selection bias and 
offering the opportunity to study rare exposures and outcomes. The data has, generally, been 
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collected prospectively and independently of the research question, which virtually eliminates 
recall bias and limits bias introduced by the influence of the diagnostic process. The data is also 
longitudinal, making it possible to study long-term effects and taking time at risk into account. 
There are, however, numerous limitations to consider. Since the data is pre-recorded and 
collected for other purposes than research, important information may be unavailable. That 
limits both what can be studied and how. For example, for our research purposes, severity 
scores of OCD and tic disorders would have been very informative and would have opened up 
the possibility of additional approaches and more detailed analyses but only the presence or 
absence of the diagnoses is available in the NPR. Additionally, some of the data, such as 
maternal smoking during pregnancy in the Medical Birth Register, is still self-reported and 
could thus be subject of information bias. 
While being limited to the variables in the registers, these variables may additionally have been 
subject to change over time or by coding practices between departments or institutions. For 
example, the medical birth reports, on which the Medical Birth Register is based, has gone 
through changes, most notably in 1982, changing the definition of some variables (e.g., elective 
and emergency cesarean section) and introducing others (e.g., maternal smoking during 
pregnancy). The changing definitions of cesarean section in the Medical Birth Register 
precluded us from looking at elective and emergency cesarean sections independently in 
studies II and III, which would have been informative of the potential mechanisms behind the 
increased risks for OCD and tic disorders. The later introduction of maternal smoking during 
pregnancy shortened the follow-up time for that specific variable and thereby reducing power 
in studies II and III. 
There may also be a lack of information in the registers. Most notably, the first registered date 
of diagnosis may not represent a very accurate approximation of date of onset. In fact, 
individuals with OCD have been shown to delay treatment for a mean of 7 years from onset.157 
This limits what conclusions can be drawn from the timing of the first recorded diagnosis, and 
also what research questions can be addressed. For example, considering studying reproductive 
cycle events in women, a first registered OCD diagnosis during postpartum may not represent 
postpartum onset, but help-seeking behavior for existing problems that have been present for 
several years. For this reason, and also due to the natural course of these disorders, which 
generally are chronic in nature, we have preferred using diagnoses of OCD and tic disorders as 
lifetime diagnoses in our studies. 
Missing data is another important limitation in register-based research and it is often not clear 
what missingness means, and whether the data is systematically missing or missing at random. 
For some variables in the Medical Birth Register, there is a considerable amount of missing 
data. For example, in studies II and III, a quarter of the birth cohort had missing values on labor 
presentation. As suggested by the National Board of Health and Welfare,96 most of these 
missing data could be assumed to be normal vaginal births. For scientific research, this 
assumption cannot be relied on, leaving two potential courses of action: imputing probable 
values based on the variable’s association to other available variables, or to let them remain 
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missing and thereby not be included in the analyses. While imputation is a valid method for 
values missing at random, it is not appropriate for values missing not at random,158 which 
cannot be assumed here. Furthermore, it is not advisable to impute values when such a large 
proportion of values are missing. With 25% of missing values for some of the variables which 
could not be assumed to be missing at random, imputation was not an option. Instead, we 
performed analyses only on the data available to us. Missing data or misclassification of 
exposure independent of the association under study should not bias any results. If there is a 
true association between the exposure and outcome, and there is false negative 
misclassification of either, then the observed results would be underestimated. In our studies, 
missing data and misclassification would thus most likely mean that the true associations are 
even stronger than reported. 
 
6.5.2 OCD and tic disorders in the National Patient Register 
Up until December 31, 2013, there were, in total, 37,868 individuals in the NPR with a 
registered OCD diagnosis, and 6,457 individuals with tic disorders, defined using the algorithm 
proposed by Rück et al.99 
Rück et al.99 confirmed that the validity of the OCD codes in ICD-10 and of the tic disorder 
codes in ICD-8, ICD-9, and ICD-10 is good. On the other hand, there were unacceptably high 
rates of false positives of OCD diagnoses in ICD-8 and ICD-9 codes, leading the authors to 
recommend that only ICD-10 codes should be used for OCD analyses. In Studies IV and V, it 
was still decided to use ICD-8 and ICD-9 codes to identify cases in order to maximize statistical 
power and follow-up time. It should, however, be noted that only a small fraction of all OCD 
cases have received the diagnosis in ICD-8 or ICD-9 only without also having a recorded ICD-
10 diagnosis at a later date. For example, in Study VI, 22,232 OCD cases were identified, and 
of these, only 349 (1.57%) had the diagnosis recorded only in ICD-8 or ICD-9. Running 
sensitivity analyses using only ICD-10 did not alter the results significantly in either study. 
Furthermore, the NPR does not cover the totality of OCD and tic disorder cases in Sweden. 
Many individuals with OCD or tic disorders do not seek help, only inpatient admissions were 
included in the NPR before 2001 and the coverage is therefore incomplete before then, and 
individuals diagnosed by general practitioners and non-specialists are not included. In fact, a 
study comparing primary care and specialist or in-patient care showed that a majority of OCD 
patients only appeared in primary care.159 Even though the characteristics of patients in our 
registers resemble patients recruited in specialist clinics globally and the prevalence of the 
disorders corresponds to register-based studies from other countries,73,74,160 it might be that our 
cases represent the more severe end of OCD and tic disorders and might not then generalize to 
individuals with milder symptoms. While we are then fairly certain that our cases were true 
cases, it is to be expected that there were a considerable number of false negative cases for both 
OCD and tic disorders. However, this misclassification likely attenuated the effects, suggesting 
that our results, if anything, are on the conservative side. 
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6.5.3 The natural experiment 
Studies II, III, V, and VI applied natural experiments, or quasi-experimental study designs, in 
order to further control for unmeasured confounding and exclude alternative explanations. 
Natural experiments signify studies of events where there is a naturally occurring contrast 
between being exposed or unexposed.161 
Randomized controlled experiments are generally regarded as the gold standard of research 
designs, offering the best possibility to make strong inferences about causality when its 
assumptions are met.162 However, there are many research questions for which randomized 
experiments are neither feasible nor ethical. This is definitely true for research on risk factors 
and long-term health consequences, where it would not be possible or ethically appropriate to 
expose a random selection of individuals to, for example, a caesarean section or smoking during 
pregnancy, to observe the outcome. Instead, researchers have to rely on correlations in 
observational data of naturally occurring events. However, statistically significant correlations 
in observational studies do not necessarily mean that there is a causal effect between exposure 
and outcome.161 The correlation can instead have alternative explanations, such as genetic 
mediation, selection bias, reverse causation, misidentification of risk factor, or a confounding 
variable.163 Still, the literature is full of correlational studies indirectly implying a causal link. 
In order to reduce the number of alternative explanations and strengthen a potential causal 
inference from observed correlations, several different quasi-experimental study designs have 
been devised. The difference between a traditional experiment and a quasi-experiment is that 
the latter lack random assignment.161 Quasi-experiments are methods designed to control for 
genetic and environmental confounding in other ways than by randomization. Individually, 
these designs do not control for all potential confounders, but when different quasi-
experimental designs with different strengths and limitations support the same conclusion, 
causal inference is greatly strengthened.164 Often, the most feasible quasi-experimental designs 
include family-based designs. By comparing differentially exposed relatives (such as full 
siblings, twins, or cousins) some of the genetic factors and a big proportion of unmeasured 
environmental factors are controlled for.164 Specifically, by comparing monozygotic twins, 
100% of the genetic factors are controlled for, whereas full sibling comparisons control for 
50% and half sibling comparisons control for 25%.134 Full sibling control designs thus 
inherently control for many unmeasured confounders that are stable within the family but may 
vary between families, such as socioeconomic factors, parental mental health history, and 
region of residence, in addition to genetic factors. 
There are also some limitations that should be taken into account when using sibling designs. 
Sibling designs do not control for potential carry-over effects, where the exposure or outcome 
of one sibling affects the exposure or outcome in another sibling.165 In studies II and III, this 
was partially addressed by adjusting for parity, since, for example, a previous cesarean section 
is an indication of another cesarean section in subsequent deliveries.  
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Sibling comparisons have lower statistical power than population-based estimates,166 resulting 
in broader confidence intervals, and the results need to be interpreted with this in mind. Only 
focusing on whether statistical significance remains may result in discarding accurate findings 
due to low statistical power.167-169 Instead, comparing the magnitude of the estimates to 
determine whether the sibling comparison confirms the population-based results is preferable. 
Because only the discordant siblings are informative in sibling controls, the results are sensitive 
to random measurement errors of the exposure and will attenuate the effects of the observed 
association.170 A recent paper demonstrated that sibling control designs control for 
confounders, but may attenuate the effect of the association by also controlling for mediators 
shared between siblings.171 Additionally, sibling controls introduce selection bias in that 
discordant siblings are more likely to be discordant for confounders as well and may result in 
spurious associations.170 
Individual quasi-experimental study designs, while being powerful tools to come closer to 
causal inference, thus also have their own limitations to take into account and do not control 
for all possible confounders. It is therefore essential to combine different designs and to a priori 
identify possible measured confounders to adjust for. 
 
6.5.4 Multiple testing problem 
None of the studies included in this thesis corrected for multiple testing. The argument for 
taking multiple testing into account is that if we keep testing different associations long enough, 
eventually something will turn out to be statistically significant. One way to counter this is to 
introduce more stringent levels of statistical significance. The Bonferroni method stipulates to 
multiply the desired significance level by number of performed tests.172 
On the other hand, the Bonferroni method assumes the general null hypothesis, that all null 
hypotheses are true at the same time and applies only if the two groups are identical on all 
variables. Receiving a Bonferroni-corrected significant result would then signify that at least 
one of the variables is truly significantly different, but would not actually indicate which one. 
Furthermore, interpretation of results would be dependent on how many other tests were 
performed, which could easily lead to dismissing true findings.173 Most importantly, the 
Bonferroni method requires that tests be independent,172 which does not apply to the exposures 
or outcomes in studies II, III, IV, and VI of this thesis. 
A preferable course of action, which we chose to take in this thesis was to base the research 
hypotheses on previous research, describe the methods in great detail, discuss the 
interpretations and their plausibility, and to promote replication studies in other populations. 
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6.6 ETHICAL CONSIDERATIONS 
The ethical dilemma of epidemiological, register-based research on psychiatric disorders is that 
sensitive personal data is processed, which constitutes an infringement on the integrity of the 
individuals unless there is informed consent. On the one hand, the Law on Ethical Vetting 
(LOE)174 requires informed consent from all the participants (LOE 16-17§). On the other hand, 
there is no feasible way to collect informed consent from millions of people and there are no 
other methods by which to address pertinent research questions involving etiology and long-
term health consequences. However, there are exceptions to the requirement of informed 
consent, such as if the research can be regarded as being of public interest. (LOE 20-22§). 
Research conducted in Sweden that involves individual human beings is regulated by the 
Ethical Review Act (2003:460) and requires approval from an ethical vetting process. The 
vetting process takes into account human rights and fundamental liberties, that the welfare of 
the individual is of greater concern than societal or scientific values, and that potential gain of 
knowledge outweighs potential risks of physical injury, mental injury, or violation of integrity 
that the study participants are exposed to. Furthermore, the Personal Information Act (PUL)175 
9§ requires that only the bare minimum of information is acquired, that this information has to 
be necessary for the study, and that it is used only for the defined purpose of the project. It is 
therefore of importance to determine exactly what information is needed for the project a 
priori. 
Mental health data is considered sensitive personal data (PUL 18§), and therefore ethical 
vetting was required for studies II-VI in this PhD project. The studies in this PhD project were 
conducted in close collaboration with the department of Medical Epidemiology and 
Biostatistics and were thereby covered by their obtained ethical approval for studies 
investigating the associations between risk factors and the risk for psychiatric disorders as well 
as the underlying mechanisms (DNR 2013/862-31/5). 
The data for this project have been acquired from registers at central authorities and national 
registers in Sweden. Before the data is obtained for this project, the personal identification 
numbers were replaced by unique ID numbers and the key is only held at the National Board 
of Health and Welfare for future updates. Still, with the great amount and detail of information 
available in the registers, it would be theoretically possible to identify individuals through the 
combination of key data. However, protecting the privacy and integrity of the participants and 
not misuse any information discovered should be of highest priority. Furthermore, all results 
should always be presented in an aggregated form so that identification of individual 
participants is not possible. When studying very rare events, the combinations of which may 
result in frequencies of very few affected people, these should not be reported as to avoid 
undeliberate identification. The data is handled and stored in a secure way to minimize the risk 
of data misuse. 
The etiology and consequences of OCD and tic disorders have so far been neglected in research. 
The gap in knowledge about these disorders may obscure identifying early detection and the 
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development of improved intervention strategies. Meanwhile, these disorders are associated 
with great impairment and disability of the patients as well as societal costs. The studies in this 
thesis address research questions that may be of value to the individual patients as well as to 
further research. It is our firm position that the potential benefits of this research, greatly 
outweigh the marginal risks to the individuals included in these studies. 
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7 CONCLUSIONS 
While numerous potential environmental risk factors for OCD and tic disorders have been 
previously studied, methodological limitations have precluded any firm conclusions. The 
literature has, however, provided insight into what areas could be of importance, including birth 
complications, reproductive cycle events, stressful life events, and infections. These broad risk 
factors need to be examined in well-controlled studies, ideally at the population level, using 
prospective longitudinal data, standardized measures and genetically informative designs. 
Our empirical studies indicated that a number of adverse perinatal events were associated with 
higher risks of OCD and tic disorders, independently of shared familial confounders and 
measured covariates. These perinatal events included breech presentation, cesarean section, 
preterm birth, and low birth weight. Specific for OCD, maternal smoking during pregnancy 
was associated with an increased risk, whereas the same association for tic disorders 
disappeared in the sibling comparison. The number of adverse perinatal events exhibited 
associations in a cumulative manner, in that the greater the number of events, the greater the 
risk for OCD and tic disorders. This cumulative effect provides some hope that, in the future, 
it may be possible to derive environmental risk scores for these disorders. Future studies should 
also examine additional environmental risk factors for the disorders, as well as replicating these 
results in other populations, not least to determine whether maternal smoking during 
pregnancy, ideally objectively confirmed via cotinine levels in utero, might be a specific risk 
factor for OCD. Combined with parallel advances in genetics research, these results will further 
contribute to the understanding of the etiology of OCD and tic disorders, and also identify 
potential areas for prevention and intervention.  
Relatives of individuals with tic-related OCD are at a higher risk of developing OCD 
themselves than relatives of individuals with non-tic-related OCD. These results support the 
validity of the DSM-5 tic-related OCD specifier. Identifying homogeneous subgroups of OCD 
may inform treatment selection, earlier detection, and future studies of OCD etiology, including 
gene-searching efforts. These gene-searching efforts would also serve to uncover the nature of 
the tic-related OCD subtype. Further investigating whether these patients require different 
treatment approaches than non-tic-related OCD patients would be advisable, as prior studies 
have been inconclusive. 
OCD and tic disorders are associated with increased risks of metabolic and cardiovascular 
disorders. The risks in individuals with tic disorders were substantially higher than those in 
individuals with OCD. However, the risks in the tic disorders study were reduced to about same 
levels in the sibling comparisons, indicating that environmental or genetic components may 
partially influence both the tic disorders and the metabolic and cardiovascular disorders, or that 
the siblings of individuals with tic disorders may have undiagnosed tic disorders or other 
neuropsychiatric disorders that are associated with metabolic and cardiovascular disorders. 
Further family studies could help establish if OCD and tic disorders co-aggregate in families 
of individuals with metabolic and cardiovascular disorders. Future studies should continue 
examining other detrimental long-term health consequences. From a clinical perspective, the 
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results of our studies emphasize the importance of monitoring the long-term physical health of 
individuals with OCD and tic disorders. These results further suggest that lifestyle interventions 
may be fruitful alongside other standard evidence based treatments to reduce the risk of 
premature mortality in these patients. 
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weren’t for you. From your support, I have learnt the importance of applying myself, always 
doing my best, and to believe that I can do almost anything, that nothing is impossible. You’ve 
also always been there for me, through thick and thin, cheering me on and encouraging me. 
But also to just lean against, when I’ve needed the rest. 
Hugo and Ludvig, my sons. You have given my life new meaning. Suddenly, everything I do 
are means to your end. To rediscover the world through your eyes gives me the most happiness 
I have ever experienced. 
Maria, my wife, my love. Without your love and support, I wouldn’t be much of anything. I’m 
eternally grateful for standing by me over the last five years. You have always believed in me, 
even when I haven’t believed in myself, and that has encouraged me to keep doing my best. 
You have also filled my life with love and joy. I love you immensely. 
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